cancer gene therapy (Idun)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namecancer gene therapy (Idun)
Drug Alias NameBcl-xs therapy (Idun)
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIdun Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIdun Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A